Clinical Trials in Netherlands

• A study in healthy men to test how BI 1291583 is taken up by the body Ended
  2023-505683-11-00 Phase I (Other) Healthy volunteer trial Boehringer Ingelheim International GmbH
• A randomized, double-blind, placebo-controlled, multicenter, adaptive phase III trial to investigate the efficacy and safety of vilobelimab … Ended
  2023-506250-20-00 Phase III ulcerative pyoderma gangrenosum InflaRx GmbH
• A study to investigate the pharmacokinetics of remibrutinib in CSF in healthy participants. Ended
  2023-506760-13-00 Phase I (Other) Healthy Novartis Pharma AG
• FLUOPANC II: A performance study of SGM-101, a fluorochrome-labeled anti-carcinoembryonic antigen monoclonal antibody for fluorescence-guide… Ended
  2023-510481-27-00 Phase II Pancreatic tumor Academisch Ziekenhuis Leiden
• A first-in-human, randomized, participant and investigator blinded, placebo-controlled single and multiple ascending dose study to assess th… Ended
  2023-505542-26-00 Phase I Heart failure (HF) Novartis Pharma AG
• Ph 3b, BIC/FTC/TAF to DTG/3TC FDC, 96 Week switch, efficacy, safety, and tolerability study in ART-experienced older adults living with HIV … Ended
  2022-503137-66-00 Phase III Human immunodeficiency virus (HIV) Viiv Healthcare UK Limited
• A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended
  2022-501418-69-00 Phase III Acute Coronary Syndrome Janssen - Cilag International
• Study to assess the effects of oral cannabidiol in healthy male subjects on CNS using the NeuroCart test battery and TMS. Ended
  2023-508311-23-00 Phase II Neurological assessments Centre for Human Drug Research
• Radiotherapy plus xevinapant or placebo in older patients with locally advanced head and neck cancer Ended
  2022-502339-20-00 Phase II Squamous cell carcinoma of head and neck European Organisation For Research And Treatment Of Cancer
• A study to test the efficacy and safety of SAR442970 in adults with hidradenitis suppurativa Ended
  2022-502370-17-00 Phase II Hidradenitis suppurativa Sanofi-Aventis Recherche & Developpement
• A Phase 2 Safety, Tolerability, and Proof-of-Concept Study of VGL101 in Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids … Ended
  2022-502505-15-00 Phase II/III Leukoencephalopathy Vigil Neuroscience Inc.
• Rivaroxaban sotorasib interaction study Ended
  2023-505557-41-00 Phase IV Healthy subjects Stichting Radboud University Medical Center
• Routine versus selective protamine administration to reduce bleeding complications after transcatheter aortic valve implantation Ended
  2023-504205-36-00 Phase III/IV Aortic stenosis St Antonius Hospital
• A First in Human Study of IBC-Ab002 in Persons With Early Alzheimer's Disease (AD) Ended
  2024-511770-76-00 Phase I Alzheimer's disease Immunobrain Checkpoint Ltd.
• A randomized, double-blind, double dummy, placebo-controlled, four-way cross-over study to investigate the analgesic effects and CNS effects… Ended
  2023-505793-15-00 Phase I (Other) Chronic pain Centre for Human Drug Research
• A Phase 2 Study Evaluating INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma Ended
  2022-502476-23-00 Phase II Treatment of immunotherapy-naive patients with previously un… Incyte Corp.
• A Phase 3b, Open-label Study to Evaluate the Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents with Moderate-to-S… Ended
  2023-505558-16-00 Phase III Atopic Dermatitis Almirall S.A.
• A study to investigate the safety, tolerability and preliminary efficacy of NGI226 microparticles in patients with Achilles tendinopathy Ended
  2022-500863-10-00 Phase II Achilles Tendinopathy Novartis Pharma AG
• A study to test whether spesolimab helps people with a skin disease called hidradenitis suppurativa Ended
  2022-501074-19-00 Phase II/III Hidradenitis suppurativa Boehringer Ingelheim Espana S.A.; Boehringer Ingelheim International GmbH; Boehr…
• A Study to Assess the Effectiveness of BOTOX (Botulinum Toxin Type A) Injections for the Change of Masseter Muscle Prominence in Adult Parti… Ended
  2022-500568-37-00 Phase III Masseter Muscle Prominence Abbvie Deutschland GmbH & Co. KG
• SAD and MAD study of VES001 Ended
  2023-505847-38-00 Phase I Frontotemporal dementia (FTD) Insusense ApS
• A controlled, randomized, first-in-human study of AP31969 investigating single and multiple ascending doses and the effect of food in health… Ended
  2023-505424-57-00 Phase I Atrial Fibrillation (cardiac arrhythmia) Acesion Pharma ApS
• A Trial Investigating the pain-relieving properties of Lu AG06474 in Healthy Adult Participants Ended
  2023-503987-18-00 Phase I (Other) Pain H. Lundbeck A/S
• A Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Prurigo Nodularis Ended
  2022-501621-20-00 Phase III Prurigo Nodularis Incyte Corp.

Showing 2,137–2,160 of 2,543 trials